Schwarz Dygos Wheeler Investment Advisors LLC Boosts Stock Holdings in CVS Health Co. (NYSE:CVS)

Schwarz Dygos Wheeler Investment Advisors LLC raised its position in CVS Health Co. (NYSE:CVS) by 15.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 21,849 shares of the pharmacy operator’s stock after buying an additional 2,857 shares during the quarter. Schwarz Dygos Wheeler Investment Advisors LLC’s holdings in CVS Health were worth $1,725,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in the company. Vanguard Group Inc. increased its stake in shares of CVS Health by 0.4% in the third quarter. Vanguard Group Inc. now owns 117,162,626 shares of the pharmacy operator’s stock worth $8,180,295,000 after purchasing an additional 485,744 shares in the last quarter. FMR LLC raised its holdings in CVS Health by 29.1% during the 3rd quarter. FMR LLC now owns 27,487,238 shares of the pharmacy operator’s stock valued at $1,919,159,000 after acquiring an additional 6,194,441 shares during the period. Northern Trust Corp lifted its position in shares of CVS Health by 2.2% during the third quarter. Northern Trust Corp now owns 14,214,296 shares of the pharmacy operator’s stock worth $992,442,000 after acquiring an additional 305,564 shares in the last quarter. Royal Bank of Canada boosted its holdings in shares of CVS Health by 2.2% in the third quarter. Royal Bank of Canada now owns 14,136,920 shares of the pharmacy operator’s stock worth $987,041,000 after acquiring an additional 303,512 shares during the period. Finally, Charles Schwab Investment Management Inc. raised its stake in shares of CVS Health by 2.6% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 12,717,825 shares of the pharmacy operator’s stock valued at $864,821,000 after purchasing an additional 324,391 shares during the period. Hedge funds and other institutional investors own 80.66% of the company’s stock.

CVS Health Trading Down 0.2 %

CVS Health stock traded down $0.15 during mid-day trading on Friday, hitting $67.18. The company’s stock had a trading volume of 6,396,438 shares, compared to its average volume of 8,376,818. The business has a 50 day moving average price of $74.42 and a 200-day moving average price of $73.64. CVS Health Co. has a 12 month low of $64.41 and a 12 month high of $83.25. The stock has a market cap of $84.68 billion, a price-to-earnings ratio of 10.40, a price-to-earnings-growth ratio of 0.89 and a beta of 0.52. The company has a debt-to-equity ratio of 0.77, a current ratio of 0.86 and a quick ratio of 0.63.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, February 7th. The pharmacy operator reported $2.12 EPS for the quarter, beating analysts’ consensus estimates of $2.01 by $0.11. CVS Health had a net margin of 2.33% and a return on equity of 15.25%. The company had revenue of $93.81 billion during the quarter, compared to analyst estimates of $90.58 billion. During the same period in the prior year, the business posted $1.99 EPS. The firm’s revenue was up 11.9% compared to the same quarter last year. As a group, analysts forecast that CVS Health Co. will post 8.31 EPS for the current year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 1st. Shareholders of record on Monday, April 22nd will be given a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 3.96%. The ex-dividend date of this dividend is Friday, April 19th. CVS Health’s payout ratio is currently 41.18%.

Wall Street Analysts Forecast Growth

CVS has been the subject of a number of recent analyst reports. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $87.00 target price on shares of CVS Health in a report on Wednesday, April 10th. StockNews.com lowered shares of CVS Health from a “buy” rating to a “hold” rating in a report on Thursday, February 15th. Wells Fargo & Company reduced their price target on shares of CVS Health from $83.00 to $76.00 and set an “equal weight” rating for the company in a research report on Monday, April 8th. SVB Leerink started coverage on CVS Health in a research report on Monday, February 26th. They issued an “outperform” rating and a $88.00 price objective on the stock. Finally, Piper Sandler boosted their target price on CVS Health from $93.00 to $94.00 and gave the stock an “overweight” rating in a research report on Friday, March 15th. Four analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $89.44.

Insiders Place Their Bets

In other CVS Health news, EVP Prem S. Shah sold 29,473 shares of CVS Health stock in a transaction that occurred on Friday, February 16th. The stock was sold at an average price of $76.95, for a total transaction of $2,267,947.35. Following the sale, the executive vice president now directly owns 39,765 shares of the company’s stock, valued at approximately $3,059,916.75. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Company insiders own 0.24% of the company’s stock.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.